36 results
DEFR14A
VANI
Vivani Medical Inc
1 May 23
Revised proxy
4:49pm
in aqueous respiratory therapy delivery with Drug and Device combination products. As the Chief Technical Operations Officer, he built operations, R&D, quality … and Vice President, Medical Development for Amylin Pharmaceuticals, a biopharmaceutical company, from 2009 to 2013 where she led the R&D efforts
8-K
EX-99.2
hco66kcvxmrlej61u1yr
2 Sep 22
Entry into a Material Definitive Agreement
3:42pm
DEFM14A
2up2uu5d91u 571ufj27
24 Jun 22
Proxy related to merger
4:44pm
424B3
nc11gap4oy e9tt
24 Jun 22
Prospectus supplement
4:38pm
S-4/A
cpuf6zd4obtnrucg32h5
16 Jun 22
Registration of securities issued in business combination transactions (amended)
5:23pm
S-4
3kpb729mzvziwfm4j0an
13 May 22
Registration of securities issued in business combination transactions
5:10pm
8-K
EX-99.2
4khoz506d azvchxwr
6 Jan 21
Pixium Vision and Second Sight Medical Products announce business combination, creating a global leader in the sight restoration market
6:14am
DEFA14A
EX-99.2
6w53c0po qlj
6 Jan 21
Additional proxy soliciting materials
6:12am
8-K
EX-99.1
9todlee5yh
14 Nov 19
Second Sight Reports Third Quarter 2019 Financial Results
4:15pm
8-K
EX-99.1
awsxhg6gbm3dvrxp5afo
4 Sep 19
Regulation FD Disclosure
9:00am
8-K
EX-99.1
7ribgb70k21bwtiyz5
6 Aug 19
Second Sight Reports Second Quarter 2019 Financial Results
4:16pm